Sarcoma Drugs Market
Sarcoma Drugs Strategic Industry Research Report 2023-2024 & 2030, Competitive Profiles of 42 Players Including Amgen, Bayer, Eisai, Eli Lilly, Johnson and Johnson, Novartis, Pfizer Inc.
December 03, 2024 08:48 ET | Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Sarcoma Drugs was...
22157.jpg
Sarcoma Drugs Industry Review 2018-2023 and Forecast 2024-2028 & 2033: Amgen, Bayer, Eisai, Eli Lilly & Company, and GlaxoSmithKline Dominate the Landscape
January 24, 2024 13:43 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global sarcoma drugs market has grown strongly...